Balaxi Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	250.7	-23.87	459.63	476.58	381.37
Depreciation & Amortization	18.95	20.98	17.53	5.12	2.98
Other Operating Activities	59.21	-55.21	51.48	19.4	27.07
Change in Accounts Receivable	-550.92	-34.23	-248.01	481.34	-470.45
Change in Inventory	36.87	228.55	-63.2	-850.86	-127.86
Change in Accounts Payable	-128.6	-54.81	-158.07	274.07	191.46
Change in Other Net Operating Assets	-36.25	-32.76	1.4	-64.21	-4.55
Operating Cash Flow	-350.03	48.66	60.75	341.45	0.03
Operating Cash Flow Growth	-	-19.90%	-82.21%	1101335.48%	-
Capital Expenditures	-211.19	-6.93	-130.58	-53.21	-12.77
Sale of Property, Plant & Equipment	-	5.23	-	-	-
Cash Acquisitions	-6.45	-8.77	-19.22	-220.23	-12.79
Investment in Securities	-	-	-	34.16	-34.16
Other Investing Activities	-	-0	44.15	-45.2	-
Investing Cash Flow	-217.64	-10.46	-105.65	-284.48	-59.73
Short-Term Debt Issued	-	-	79.83	-	36.59
Long-Term Debt Issued	339.63	60.4	-	-	-
Total Debt Issued	339.63	60.4	79.83	-	36.59
Short-Term Debt Repaid	-	-	-	-0.21	-
Long-Term Debt Repaid	-0.98	-0.94	-0.89	-	-
Total Debt Repaid	-0.98	-0.94	-0.89	-0.21	-
Net Debt Issued (Repaid)	338.65	59.46	78.93	-0.21	36.59
Issuance of Common Stock	27.05	257.9	184.71	-	-
Common Dividends Paid	-	-	-4.98	-	-
Other Financing Activities	-26.93	-14.83	-3.54	-1.42	-0.13
Financing Cash Flow	338.76	302.54	255.13	-1.63	36.46
Miscellaneous Cash Flow Adjustments	-	0	-	-	-
Net Cash Flow	-228.91	340.74	210.22	55.33	-23.24
Free Cash Flow	-561.23	41.74	-69.83	288.23	-12.74
Free Cash Flow Margin	-19.18%	1.73%	-2.08%	10.32%	-0.55%
Free Cash Flow Per Share	-10.17	0.81	-1.38	5.76	-0.26
Cash Interest Paid	27.78	15.26	3.54	1.42	0.13
Cash Income Tax Paid	32.11	66.81	120.94	55.92	25.95
Levered Free Cash Flow	-658.3	398.6	-260.29	132.5	-129.86
Unlevered Free Cash Flow	-639.96	409.08	-257.16	133.39	-129.78
Change in Working Capital	-678.89	106.75	-467.88	-159.66	-411.39

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.